Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2008-04-18
2011-11-22
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S423000, C424S078370, C514S611000
Reexamination Certificate
active
08062656
ABSTRACT:
The invention provides NO-releasing polymers and low molecular weight NO-releasing compounds which may be used to for the treatment of medical conditions associated with NO-deficiency. The NO-releasing polymers or the low molecular weight NO-releasing compounds may also be incorporated into medical devices. The invention further provides methods of controlled release of NO for the treatment of diseases and disorders associated with NO-deficiency, wherein the treatment includes systemic or local administration of the NO-releasing polymers or the low molecular weight NO-releasing compounds.
REFERENCES:
patent: 6379660 (2002-04-01), Saavedra et al.
patent: 7776997 (2010-08-01), Mohanty et al.
patent: 7915377 (2011-03-01), Mohanty et al.
patent: 2005/0203272 (2005-09-01), Mohanty et al.
patent: 2006/0155103 (2006-07-01), Mohanty et al.
U.S. Appl. No. 12/105,869, filed Apr. 18, 2008, Mohanty.
Berger, K. et al., “Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rates,” Brain Research Bulletin (1991) 26:301-307.
Boje, K.M.K., “Nitric oxide neurotoxicity in neurodegenerative diseases,” Frontiers in Bioscience (2004) 9:763-776.
Columbia-Presbyterian Medical Center, “Nitric oxide in Parkinson's,” Biomedical Frontiers (1997) 4(2):1.
Fingl et al., “The Pharmacological Basis of Therapeutics,” Goodman & Gilman's, Chapter 1, p. 1-46 (1975).
Frost, M.C. et al., “Preparation and characterization of implantable sensors with nitric oxide release coatings,” Microchem. J. (2003) 74(3):277-288.
Frost, M.C. et al., “Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices,” Biomaterials (2005) 26(14):1685-1693.
Gonzalez-Zulueta, M. et al., “Requirement for nitric oxide activation of p2 lras/extracellular regulated kinase in neuronal ischemic preconditioning,” Proc. Natl. Acad. Sci. (2000) 97:436-441.
Guix, F. et al., “The physiology and pathophysiology of nitric oxide in the brain,” Progress in Neurobiology (2005) 76:126-152.
Heales, S.J.R. et al., “Neurodegeneration or neuroprotection: the pivotal role of astrocytes,” J. Neurochem. Res. (2004) 29(3):513-519.
Mohanakumar, K.P. et al., “Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity,” J. Chem. Neuroanat. (1998) 14(3-4):195-205.
Mohanakumara, K.P. et al., “Nitric oxide: an antioxidant and neuroprotector,” Ann. N.Y. Acad. Sci. (2002) 962:389-401.
Oh, J.D. et al., “Protein kinase a inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat,” Neuroscience Letters (1997) 228(1):5-8.
Pan, Z-H, et al., “Nitric-oxide-related species inhibit evoked neurotransmission by enhance spontaneous miniature synaptic currents in central neuronal cultures,” Proc. Natl. Acad. Sci. USA (1996) 93(26):15423-15428.
Rauhala, P. et al., “Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress,” FASEB J. (1998) 12:165-173.
Reynolds, M.M. et al., “Nitric oxide-releasing hydrophobic polymers: preparation, characterization, and potential biomedical applications,” Free Radical Biology & Medicine (2004) 37(7):926-936.
Thomas, T. et al., “L-deprenyl: nitric oxide production and dilation of cerebral blood vessels,” NeuroReport (1998) 9(1):2595-2600.
Tillerson, J.L et al., “Exercise induced behavioral recovery and attenuates neurochemical deficits in roden models of Parkinson's disease,” Neurosci. (2003) 119:899-911.
Vidwans, A.S. et al., “Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture,” J. Neurochem. (1999) 72(5):1843-1852.
Wu, Y. et al., “Nitric oxide-releasing/generating polymers for the development of implantable chemical sensors with enhanced biocompatibility,” Talanta (2008) 75(3):642-650.
Zigmond, M.J. et al., “Pathophysiology of Parkinson's disease,” Neuropsychopharmacology: The Fifth Generation of Progress, eds. Davis, K.L. et al., American College of Neuropsychopharmacology (2002) 1781-1794.
United States Patent Office Action for U.S. Appl. No. 12/105,869 dated Apr. 26, 2011 (19 pages).
Mohanty Dillip K.
Oh-Lee Justin D.
Al-Awadi Danah
Central Michigan University
Michael & Best & Friedrich LLP
Wax Robert A
LandOfFree
Methods of treating disease with nitric oxide (NO)-releasing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating disease with nitric oxide (NO)-releasing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating disease with nitric oxide (NO)-releasing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4279656